Accuray Inc (ARAY)
1.695
+0.10
(+5.94%)
USD |
NASDAQ |
May 15, 16:00
1.695
0.00 (0.00%)
After-Hours: 16:31
Accuray Cash from Financing (Quarterly): -1.50M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.50M |
December 31, 2023 | -0.257M |
September 30, 2023 | -1.50M |
June 30, 2023 | -0.522M |
March 31, 2023 | -1.50M |
December 31, 2022 | 4.275M |
September 30, 2022 | -4.365M |
June 30, 2022 | 0.141M |
March 31, 2022 | -1.00M |
December 31, 2021 | -13.51M |
September 30, 2021 | -1.00M |
June 30, 2021 | -19.41M |
March 31, 2021 | 1.63M |
December 31, 2020 | 0.136M |
September 30, 2020 | -11.16M |
June 30, 2020 | -1.63M |
March 31, 2020 | 5.442M |
December 31, 2019 | -4.566M |
September 30, 2019 | 27.45M |
June 30, 2019 | 13.76M |
March 31, 2019 | 8.812M |
December 31, 2018 | 8.327M |
September 30, 2018 | -2.426M |
June 30, 2018 | -2.813M |
March 31, 2018 | -36.35M |
Date | Value |
---|---|
December 31, 2017 | 12.88M |
September 30, 2017 | -1.167M |
June 30, 2017 | -13.11M |
March 31, 2017 | -0.254M |
December 31, 2016 | -5.69M |
September 30, 2016 | -35.48M |
June 30, 2016 | 0.237M |
March 31, 2016 | -0.208M |
December 31, 2015 | -0.76M |
September 30, 2015 | -0.026M |
June 30, 2015 | 1.183M |
March 31, 2015 | 2.072M |
December 31, 2014 | 0.754M |
September 30, 2014 | 1.886M |
June 30, 2014 | 1.183M |
March 31, 2014 | 3.33M |
December 31, 2013 | 3.235M |
September 30, 2013 | 0.629M |
June 30, 2013 | 1.90M |
March 31, 2013 | 110.87M |
December 31, 2012 | 4.896M |
September 30, 2012 | 0.251M |
June 30, 2012 | 1.745M |
March 31, 2012 | 0.674M |
December 31, 2011 | 1.119M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-19.41M
Minimum
Jun 2021
27.45M
Maximum
Sep 2019
-0.4544M
Average
-1.00M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 1.569B |
Integer Holdings Corp | 163.29M |
ResMed Inc | -335.91M |
Glaukos Corp | 13.17M |
Perspective Therapeutics Inc | 0.352M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -8.102M |
Cash from Investing (Quarterly) | -0.795M |
Free Cash Flow | -24.08M |
Free Cash Flow Per Share (Quarterly) | -0.0897 |
Free Cash Flow to Equity (Quarterly) | -7.633M |
Free Cash Flow to Firm (Quarterly) | -5.796M |
Free Cash Flow Yield | -14.59% |